Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans

Eliza B. de Sousa Fernandes Perna, Eef L. Theunissen, Patrick C. Dolder, Natasha L. Mason, Nadia R. P. W. Hutten, Stefan W. Toennes, Kim P. C. Kuypers, Johannes G. Ramaekers*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number713
Number of pages11
JournalFrontiers in Pharmacology
Volume9
DOIs
Publication statusPublished - 6 Jul 2018

Keywords

  • 4-FA
  • phase-1
  • safety
  • neurocognition
  • novel psychoactive substance
  • PSYCHOACTIVE SUBSTANCES NPS
  • MDMA 75 MG
  • D-AMPHETAMINE
  • MEPHEDRONE TOXICITY
  • HEALTHY-VOLUNTEERS
  • MEMORY IMPAIRMENT
  • ACUTE TOLERANCE
  • MOOD
  • METHAMPHETAMINE
  • METHYLPHENIDATE

Cite this

@article{0c8b2b16938646d996092047b1076c55,
title = "Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans",
keywords = "4-FA, phase-1, safety, neurocognition, novel psychoactive substance, PSYCHOACTIVE SUBSTANCES NPS, MDMA 75 MG, D-AMPHETAMINE, MEPHEDRONE TOXICITY, HEALTHY-VOLUNTEERS, MEMORY IMPAIRMENT, ACUTE TOLERANCE, MOOD, METHAMPHETAMINE, METHYLPHENIDATE",
author = "Perna, {Eliza B. de Sousa Fernandes} and Theunissen, {Eef L.} and Dolder, {Patrick C.} and Mason, {Natasha L.} and Hutten, {Nadia R. P. W.} and Toennes, {Stefan W.} and Kuypers, {Kim P. C.} and Ramaekers, {Johannes G.}",
year = "2018",
month = "7",
day = "6",
doi = "10.3389/fphar.2018.00713",
language = "English",
volume = "9",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S.A.",

}

TY - JOUR

T1 - Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans

AU - Perna, Eliza B. de Sousa Fernandes

AU - Theunissen, Eef L.

AU - Dolder, Patrick C.

AU - Mason, Natasha L.

AU - Hutten, Nadia R. P. W.

AU - Toennes, Stefan W.

AU - Kuypers, Kim P. C.

AU - Ramaekers, Johannes G.

PY - 2018/7/6

Y1 - 2018/7/6

KW - 4-FA

KW - phase-1

KW - safety

KW - neurocognition

KW - novel psychoactive substance

KW - PSYCHOACTIVE SUBSTANCES NPS

KW - MDMA 75 MG

KW - D-AMPHETAMINE

KW - MEPHEDRONE TOXICITY

KW - HEALTHY-VOLUNTEERS

KW - MEMORY IMPAIRMENT

KW - ACUTE TOLERANCE

KW - MOOD

KW - METHAMPHETAMINE

KW - METHYLPHENIDATE

U2 - 10.3389/fphar.2018.00713

DO - 10.3389/fphar.2018.00713

M3 - Article

VL - 9

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

M1 - 713

ER -